New pill cocktail aims to fight cancers that stopped responding to treatment
NCT ID NCT07287917
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tests whether adding two oral drugs (AMXT 1501 and DFMO) to standard treatments can help people with advanced solid tumors that have stopped responding to prior therapies. The trial includes two groups: one with a type of breast cancer and another with melanoma. The goal is to find the right dose and see if the combination shrinks tumors or slows disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Laguna Clinical Research Associates
RECRUITINGLaredo, Texas, 78041, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lumi Research
RECRUITINGHouston, Texas, 77090, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Cancer Research New York-Long Island
RECRUITINGLake Success, New York, 11042, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Los Angeles
RECRUITINGLos Angeles, California, 90025, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Mountain Region
RECRUITINGWest Valley City, Utah, 84119, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skin Cancer Institute
RECRUITINGEnglewood, Colorado, 80113, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cincinnati Medical Center
RECRUITINGCincinnati, Ohio, 45219, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas-MD Anderson
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Wisconsin-Madison Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53706, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Vanderbilt-Ingram Cancer Institute
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Virginia Cancer Specialists-Fairfax
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wayne State University - Barbara Ann Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.